Apollo Hospitals Enterprise Ltd (AHEL), one of the market’s top players, has seen tremendous growth in the Indian healthcare sector over the past few years. AHEL is a privately held business that offers medical services and manages pharmacies, clinics, and hospitals in India. Investors have been keenly watching AHEL’s financial results and growth prospects since the company’s share price has steadily increased over the years. Many people are unsure of what the future holds for the share price of AHEL given that the healthcare sector is anticipated to grow even more in the upcoming years. In this article, we’ll look at the variables that could have an impact on AHEL’s share price projection between 2023 and 2030 and offer some insights into the company’s potential for growth.
CLICK HERE FOR MORE:
STOCK HISTORY OF APOLLO HOSPITALS ENTERPRISES:
Apollo Hospitals Enterprise is a publicly traded company listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE). Among all hospitals, it holds the top position in terms of market capitalization.
The company’s shares made their debut on the stock exchanges back in 1994, marking the beginning of an interesting journey for its stock price. Initially, the stock showed stability with modest growth. However, the late 1990s witnessed a substantial surge in its value, primarily fueled by the increasing demand for high-quality healthcare services in India. This upward trajectory persisted throughout the following decade, with the stock price hitting its pinnacle in 2007.
Nonetheless, the global financial crisis of 2008 had a profound impact on the stock market, including Apollo Hospitals Enterprise. The company’s stock value declined significantly, aligning with the broader downturn in healthcare stocks, as investors grew cautious about the industry’s future prospects. Despite these challenging market conditions, the company’s management took proactive steps to enhance its financial performance, leading to a gradual recovery in the stock price over subsequent years.
In recent times, Apollo Hospitals Enterprise has maintained its growth momentum and expanded its operations both domestically and internationally. This has been reflected in its stock price, which has steadily climbed. As of 2023, the stock is trading at Rs. 4,621.
HOW TO BUY APOLLO SHARES?
You have the option to purchase shares of Apollo Hospitals Enterprise through the following trading platforms:
APOLLO IN RECENT NEWS
- Apollo Hospital’s stock price declines in tandem with a 734.25-point drop in Sensex.
- Apollo Facilities Enterprises Ltd, a prominent healthcare organization in India, aims to increase the average occupancy rate across all its facilities to 68-70% in the fiscal year 2024.
- Apollo Hospitals intends to expand its presence by establishing two additional proton cancer centers in India.
- Apollo Hospitals faces a decline, leaving investors underwhelmed, but brokerage firms remain optimistic about the future potential of its 24/7 services.
- Pfizer India and Apollo Hospital have jointly established a Center of Excellence (CoE) for adult immunization in Hyderabad. The CoE, situated at Apollo Hospital in Hyderabad, has been established with the aim of enhancing the adoption of adult immunization to safeguard patients against vaccine-preventable diseases (VPDs).
APOLLO SHARE PRICE TARGET 2023
|APOLLO SHARE PRICE TARGET 2023||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) has a positive outlook for 2023, as indicated by the share price predictions in the table above. Despite some fluctuations throughout the year, AHEL is expected to finish the year on an overall uptrend. The maximum share price for December 2023 is predicted to be ₹5,217.30, which represents an impressive growth percentage from the minimum price in March 2023 of approximately 132%. These trends suggest that AHEL may be a strong investment opportunity in the healthcare sector for the coming year.
APOLLO SHARE PRICE TARGET 2024
|APOLLO SHARE PRICE TARGET 2024||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) is expected to continue its bullish run into 2024, according to share price predictions for the year. The maximum share price target for the year is predicted to be ₹10,806.86 in December 2024, which represents an impressive growth percentage from the minimum price in May 2024 of approximately 93%. AHEL’s share price is projected to reach new highs in October and November 2024, with targets of ₹10,090.44 and ₹10,594.96, respectively. Despite some slight fluctuations in the first half of the year, AHEL is expected to end 2024 on an overall uptrend. The minimum share price target for the year is predicted to be ₹5,600.20 in May 2024. These projections suggest that AHEL may continue to be a strong investment opportunity in the healthcare sector, with a potential for significant returns in the coming years.
APOLLO SHARE PRICE TARGET 2025
|APOLLO SHARE PRICE TARGET 2025||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) is expected to continue its bullish trend into 2025, with share price predictions for the year indicating potential for further growth. The maximum share price target for 2025 is projected to be ₹13,108.90 in December, which represents a significant growth percentage from the minimum price in May of approximately 75%. AHEL’s share price is expected to reach new highs in October and November 2025, with targets of ₹12,011.08 and ₹12,851.86, respectively. Although there may be some slight fluctuations in the first half of the year, overall, AHEL is predicted to continue its uptrend. The minimum share price target for the year is projected to be ₹7,606.97 in May 2025. These share price predictions suggest that AHEL may continue to be a strong investment opportunity in the healthcare sector, with the potential for significant returns in the coming years.
APOLLO SHARE PRICE TARGET 2026 TO 2030
|APOLLO SHARE PRICE TARGET BY||Maximum Price||Minimum Price|
Based on the provided data, the maximum and minimum share price targets for Apollo Hospital for the years 2026 to 2030 are as follows: In 2026, the maximum and minimum prices are expected to be ₹9,176.23 and ₹6,423.36, respectively. In 2027, the prices are expected to decrease, with a maximum of ₹7,799.79 and a minimum of ₹5,459.85. However, in 2028, there is a significant increase in the share price, with a maximum of ₹14,039.63 and a minimum of ₹9,827.74. This trend is expected to continue in 2029, with a maximum price of ₹28,839.57 and a minimum of ₹20,187.70. In 2030, the maximum price is expected to be ₹32,116.79, while the minimum price is expected to be ₹22,481.76. It is important to note that these figures are based on historical trends and future market conditions can significantly affect the actual share prices.
CLICK HERE FOR MORE:
FINANCIAL STRENGTH OF APOLLO (2019 TO 2023)
|Sales (Rs crore)||9,617||11,247||10,560||14,663||16,612|
|Expenses (Rs crore)||8,548||9,656||9,420||12,474||14,548|
|Operating Profit (Rs crore)||1,070||1,591||1,140||2,189||2,065|
|Other Income (Rs crore)||26||222||103||368||75|
|Interest (Rs crore)||327||533||449||379||381|
|Depreciation (Rs crore)||396||620||573||601||615|
|Profit before tax (Rs crore)||373||660||221||1,578||1,144|
|Net Profit (Rs crore)||200||432||137||1,108||844|
|EPS in Rs||16.96||32.70||10.46||73.42||56.97|
|Dividend Payout %||35%||18%||29%||16%||26%|
Over the last five years, the company has showcased a notable financial journey characterized by substantial revenue growth. Sales escalated from Rs 9,617 crore in 2019 to Rs 16,612 crore in the trailing twelve months of 2023, reflecting robust market performance. While operating profit margins (OPM %) exhibited fluctuations, they remained relatively healthy, reaching 15% in 2022. Despite fluctuations in net profit and a relatively high tax percentage in the initial years, the company’s bottom line demonstrated resilience and substantial growth, with net profit surging from Rs 200 crore in 2019 to Rs 844 crore in 2023. The earnings per share (EPS) also witnessed remarkable growth during this period, reaching Rs 56.97. The dividend payout ratio fluctuated but generally provided shareholders with consistent returns. These financial trends suggest the company’s ability to navigate changing market dynamics and capitalize on growth opportunities.
POINTS TO KEEP IN MIND WHILE INVESTING IN APOLLO SHARES:
- Over the past five years, the company has achieved impressive profit growth with a CAGR of 67.1%.
- The company consistently maintains a robust dividend payout ratio of 23.7%.
- The stock is currently trading at a valuation of 11.8 times its book value.
- However, the company has demonstrated a relatively low return on equity, averaging 11.7% over the last three years.
APOLLO SHARE PRICE TARGET BY EXPERTS:
- Edelweiss recommends buying Apollo Hospitals Enterprise shares and sets a target price of Rs 5200.(1June, 2023)
- ICICI Securities advises purchasing Apollo Hospitals Enterprise listed on the National Stock Exchange, with a target price of Rs 4736.(16 August,2023)
- ICICI Direct suggests buying Apollo Hospitals shares with a target price of Rs. 5460.(16 August,2023)
- Kotak Institutional Equities recommends buying Apollo Hospitals shares with a target price of Rs. 5470.(22 December, 2023)
- Motilal Oswal gives a buy rating to Apollo Hospitals shares with a price projection of Rs. 5600.(17 January 2023)
The maximum share price target of Apollo Hospital in 2026 is Rs. 9176.23
The maximum share price target of Apollo Hospital in 2027 is Rs. 7799.79
The maximum share price target of Apollo Hospital in 2028 is Rs.14039.63
The maximum share price target of Apollo Hospital in 2029 is Rs. 28839.57
The maximum share price target of Apollo Hospital in 2030 is Rs. 32116.79
CONCLUSION: APOLLO HOSPITALS
Apollo’s financial performance over the past five years, depicted in the table, tells a story of consistent growth and resilience. The company has impressively increased its sales, with revenues surging from Rs 9,617 crore in 2019 to Rs 16,612 crore in the trailing twelve months of 2023, showcasing its ability to capture market opportunities. It may be said that Apollo Hospitals has fared well recently based on the general growth trend in sales, PAT, and operating profit margin. But, a number of additional factors, such as market volatility, industry competitiveness, and prevailing economic conditions, also have an impact on share prices. Apollo’s financial performance over the past five years, as indicated in the table, demonstrates a positive growth trajectory. Despite fluctuations, the company has shown resilience in revenue and profitability. Expert recommendations suggest a favorable outlook, reinforcing Apollo’s potential as a sound investment option in the healthcare sector.
Suhani Bhat, a student of Hansraj college, is a finance writer who takes deep interest in stock market, mutual funds, and other financial news. She writes for multiple finance blogs, including Financegradeup.com. Other than English, she also speaks Hindi.